Validated HPLC-MS/MS method for determination of quetiapine in human plasma

Journal of Pharmaceutical and Biomedical Analysis

Volumn 44, Issue 2, 2007, Pages 498-505

  Barrett, B ^a   Holcapek M ^b   Huclova J ^a   Borek Dohalsky V ^a   Fejt, P ^a   Nemec B ^a   Jelinek I ^c  

^a CEPHA sro Plzen ^*  (Czech Republic)

^b UNIVERSITY OF PARDUBICE   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

HPLC; MS MS; Pharmacokinetic study; Plasma; Quetiapine

Indexed keywords

CLOZAPINE; EDETIC ACID; QUETIAPINE;

ACCURACY; ARTICLE; CONCENTRATION (PARAMETERS); DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG DISTRIBUTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PLASMA; PRIORITY JOURNAL; SOLID PHASE EXTRACTION; STANDARD; TANDEM MASS SPECTROMETRY;

ANTIPSYCHOTIC AGENTS; AREA UNDER CURVE; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, LIQUID; DIBENZOTHIAZEPINES; DRUG STABILITY; HUMANS; MASS SPECTROMETRY; QUALITY CONTROL; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; THERAPEUTIC EQUIVALENCY;

EID: 34249984437     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2007.03.034     Document Type: Article

References (15)

1. The Complete Drug Reference (Monograph on CD-ROM) (2003), Pharmaceutical Press, London
2. Seroquel™. Summary of Product Characteristics vol. 23 (2003), AstraZeneca UK Limited
3. http://www.rxlist.com/cgi/generic2/quetiap_pi.htm, 2003, p. 31.
4. DeVane C.L., and Nemeroff C.B. Clin. Pharmacokinet. 40 (2001) 509-522
5. Thyrum P.T., Wong Y.W., and Yeh C. Prog. Neuropsychopharmacol. Biol. Psychiatry 24 (2000) 521-533
6. Diletti E., Hauschke D., and Steinijans V.W. Int. J. Clin. Pharmacol. Ther. Toxicol. 29 (1991) 1-8
7. Davis P.C., Wong J., and Gefvert O. J. Pharm. Biomed. Anal. 20 (1999) 271-282
8. Mandrioli R., Fanali S., Ferranti A., and Raggi M.A. J. Pharm. Biomed. Anal. 30 (2002) 969-977
9. Frahnert C., Rao M.L., and Grasmaeder K. J. Chomatogr. B 794 (2003) 35-47
10. Hasselstrom J., and Linet K. J. Chomatogr. B 798 (2003) 9-16
11. Anderson D.T., and Fritz K.L. J. Anal. Toxicol. 24 (2000) 300-304
12. Pelander A., Ojanpera I., Sistonen J., Rasenen I., and Vuori E. J. Anal. Toxicol. 27 (2003) 226-232
13. Zhou Z., Li X., Li K., Xie Z., Cheng Z., Peng W., Wang F., Zhu R., and Li H. J. Chomatogr. B 802 (2004) 257-262
14. U.S. Department of Health and Human Services, Food and Drug Administration, Centre for Veterinary Medicine, Guideline No. 135, Validation of Analytical Procedures for Type C Medicated Feeds, November 7, 2005.
15. McConville B.J., Arvanitis L.A., Thyrum P.T., Yeh C., Wilkinson L.A., Chaney R.O., Foster K.D., Sorter M.T., Friedman L.M., Brown K.L., and Heubi J.E. J. Clin. Psychiatry 61 (2000) 252-260